{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,3,29]],"date-time":"2022-03-29T12:05:36Z","timestamp":1648555536537},"reference-count":20,"publisher":"Pharmaceutical Society of Japan","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biological &amp; Pharmaceutical Bulletin","Biol. Pharm. Bull."],"published-print":{"date-parts":[[2014]]},"DOI":"10.1248\/bpb.13-00558","type":"journal-article","created":{"date-parts":[[2014,1,31]],"date-time":"2014-01-31T23:10:07Z","timestamp":1391209807000},"page":"311-314","source":"Crossref","is-referenced-by-count":3,"title":["Detection of Antibodies to Human T-Cell Leukemia Virus Types 1 and 2 in Breast Milk from East Asian Women"],"prefix":"10.1248","volume":"37","author":[{"given":"Futoshi","family":"Matsubara","sequence":"first","affiliation":[{"name":"Department of Microbiology and Biochemistry, Daiichi University of Pharmacy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasuko","family":"Sagara","sequence":"additional","affiliation":[{"name":"Department of Quality, Japanese Red Cross Kyushu Block Blood Center"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshihisa","family":"Kato","sequence":"additional","affiliation":[{"name":"Department of Pharmacokinetics and Pharmacodynamics, Kagawa School of Pharmaceutical Sciences, Tokushima Bunri University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kouji","family":"Harada","sequence":"additional","affiliation":[{"name":"Department of Health and Environmental Sciences, Kyoto University Graduate School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akio","family":"Koizumi","sequence":"additional","affiliation":[{"name":"Department of Health and Environmental Sciences, Kyoto University Graduate School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Koichi","family":"Haraguchi","sequence":"additional","affiliation":[{"name":"Department of Analytical Chemistry, Daiichi University of Pharmacy"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"163","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1) \u2003Yamaguchi K, Watanabe T. Human T lymphotropic virus type-I and adult T-cell leukemia in Japan. <i>Int. J. Hematol.<\/i>, 76 (Suppl. 2), 240\u2013245 (2002).","DOI":"10.1007\/BF03165123"},{"key":"2","unstructured":"2) \u2003Mylonas I, Br\u00fcning A, Kainer F, Friese K. HTLV infection and its implication in gynaecology and obstetrics. <i>Arch. Gynecol. Obstet.<\/i>, 282, 493\u2013501 (2010)."},{"key":"3","doi-asserted-by":"crossref","unstructured":"3) \u2003Iwanaga M, Watanabe T, Utsunomiya A, Okayama A, Uchimaru K, Koh KR, Ogata M, Kikuchi H, Sagara Y, Uozumi K, Mochizuki M, Tsukasaki K, Saburi Y, Yamamura M, Tanaka J, Moriuchi Y, Hino S, Kamihira S, Yamaguchi K. Human T-cell leukemia virus type I (HTLV-1) proviral load and disease progression in asymptomatic HTLV-1 carriers: a nationwide prospective study in Japan. <i>Blood<\/i>, 116, 1211\u20131219 (2010).","DOI":"10.1182\/blood-2009-12-257410"},{"key":"4","unstructured":"4) \u2003Ureta-Vidal A, Angelin-Duclos C, Tortevoye P, Murphy E, Lep\u00e8re JF, Buigues RP, Jolly N, Joubert M, Carles G, Pouliquen JF, de Th\u00e9 G, Moreau JP, Gessain A. Mother-to-child transmission of human T-cell-leukemia\/lymphoma virus type I: implication of high antiviral antibody titer and high proviral load in carrier mothers. <i>Int. J. Cancer<\/i>, 82, 832\u2013836 (1999)."},{"key":"5","doi-asserted-by":"crossref","unstructured":"5) \u2003Sonoda S. Present status of HTLV-I infections in developing countries and the countermeasures. <i>Uirusu<\/i>, 43, 93\u2013100 (1993).","DOI":"10.2222\/jsv.43.93"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6) \u2003Proietti FA, Carneiro-Proietti ABF, Catalan-Soares BC, Murphy EL. Global epidemiology of HTLV-I infection and associated diseases. <i>Oncogene<\/i>, 24, 6058\u20136068 (2005).","DOI":"10.1038\/sj.onc.1208968"},{"key":"7","unstructured":"7) \u2003Higuchi M, Fujii M. Distinct functions of HTLV-1 Tax1 from HTLV-2 Tax2 contribute key roles to viral pathogenesis. <i>Retrovirology<\/i>, 6, 117 (2009)."},{"key":"8","unstructured":"8) \u2003Matsubara F, Haraguchi K, Harada K, Koizumi A. Screening for antibodies to Human T-cell Leukemia Virus type 1 in Japanese breast milk. <i>Biol. Pharm. Bull.<\/i>, 35, 773\u2013776 (2012)."},{"key":"9","unstructured":"9) \u2003Koizumi A, Harada KH, Inoue K, Hitomi T, Yang HR, Moon CS, Wang P, Hung NN, Watanabe T, Shimbo S, Ikeda M. Past, present, and future of environmental specimen banks. <i>Environ. Health Prev. Med.<\/i>, 14, 307\u2013318 (2009)."},{"key":"10","unstructured":"10) )\u2003Fujirebio Inc., Tokyo, Global Sales Department. \u201cSerological test for antibodies to human T lymphotropic retrovirus type I\u2014Particle-Agglutination Test for the Detection of Antibodies to Human T Lymphotropic Retrovirus type I (HTLV-I).\u201d: \u2039http:\/\/www.fujirebio.co.jp\/english\/product\/serodia.html#03\u203a, cited September, 2012."},{"key":"11","unstructured":"11) \u2003Washitani Y, Kuroda N, Shiraki H, Itoyama Y, Sato H, Ohshima K, Kiyokawa H, Maeda Y. Linear antigenic regions of the structural proteins of human T-cell lymphotropic virus type I as detected by enzyme-linked immunosorbent assays using synthetic peptides antigens. <i>J. Clin. Microbiol.<\/i>, 30, 287\u2013290 (1992)."},{"key":"12","unstructured":"12) \u2003Berini CA, Susana Pascuccio M, Bautista CT, Gendler SA, Eirin ME, Rodriguez C, Pando MA, Biglione MM. Comparison of four commercial screening assays for the diagnosis of human T-cell lymphotropic virus types 1 and 2. <i>J. Virol. Methods.<\/i>, 147, 322\u2013327 (2008)."},{"key":"13","unstructured":"13) \u2003Zane L, Sibon D, Mortreux F, Wattel E. Clonal expansion of HTLV-1 infected cells depends on the CD4 versus CD8 phenotype. <i>Front Biosci.<\/i> (Landmark Ed.), 14, 3935\u20133941 (2009)."},{"key":"14","unstructured":"14) \u2003Kwon KW, Yano M, Sekiguchi S, Iwanaga M, Fujiwara S, Oikawa O, Sugiura M, Imai S, Osato T. Prevalence of human T-cell leukemia virus type 1 (HTLV-I) in general inhabitants in non-adult T-cell leukemia (ATL)-endemic Hokkaido, Japan. <i>In Vivo<\/i>, 8, 1011\u20131014 (1994)."},{"key":"15","unstructured":"15) \u2003Malm K, Ekermo B, Hillgren K, Britton S, Fredlund H, Andersson S. Prevalence of human T-lymphotropic virus type 1 and 2 infection in Sweden. <i>Scand. J. Infect. Dis.<\/i>, 44, 852\u2013859 (2012)."},{"key":"16","unstructured":"16) \u2003Trevi\u00f1o A, Aguilera A, Caballero E, Benito R, Parra P, Eiros JM, Hernandez A, Calder\u00f3n E, Rodr\u00edguez M, Torres A, Garc\u00eda J, Ramos JM, Roc L, Marcaida G, Rodr\u00edguez C, Trigo M, Gomez C, de Lejarazu RO, de Mendoza C, Soriano V, HTLV Spanish Study Group. Trends in the prevalence and distribution of HTLV-1 and HTLV-2 infections in Spain. <i>Virology J.<\/i>, 9, 71 (2012)."},{"key":"17","unstructured":"17) \u2003Pinto MT, Rodrigues ES, Malta TM, Azevedo R, Takayanagui OM, Valente VB, Ubiali EM, Covas DT, Kashima S. HTLV-1\/2 seroprevalence and coinfection rate in Brazilian first-time blood donors: an 11-year follow-up. <i>Rev. Inst. Med. Trop. S\u00e3o Paulo<\/i>, 54, 123\u2013129 (2012)."},{"key":"18","doi-asserted-by":"crossref","unstructured":"18) \u2003Ma Y, Zheng S, Wang N, Duan Y, Sun X, Jin J, Zang W, Li M, Wang Y, Zhao G. Epidemiological analysis of HTLV-1 and HTLV-2 infection among different population in Central China. <i>PLOS ONE<\/i> www.plosone.org, 8, e66795 (2013).","DOI":"10.1371\/journal.pone.0066795"},{"key":"19","unstructured":"19) \u2003Kwon SY, Lim AH, Park JY, Han SH, Cho NS. Seroprevalence of human T-lymphotropic virus type 1 and 2 Korean blood donnors. <i>J. Med. Virol.<\/i>, 80, 1864\u20131867 (2008)."},{"key":"20","doi-asserted-by":"crossref","unstructured":"20) \u2003Abrams A, Akahata Y, Jacobson S. The prevalence and significance of HTLV-I\/II seroindeterminate Western blot patterns. <i>Viruses<\/i>, 3, 1320\u20131331 (2011).","DOI":"10.3390\/v3081320"}],"container-title":["Biological and Pharmaceutical Bulletin"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/bpb\/37\/2\/37_13-00558\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,2,18]],"date-time":"2021-02-18T01:07:24Z","timestamp":1613610444000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/bpb\/37\/2\/37_13-00558\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014]]},"references-count":20,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2014]]}},"URL":"https:\/\/doi.org\/10.1248\/bpb.13-00558","relation":{},"ISSN":["0918-6158","1347-5215"],"issn-type":[{"value":"0918-6158","type":"print"},{"value":"1347-5215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014]]}}}